Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bayer d.o.o. - levonorgestrel - intrauterini dostavni sistem - levonorgestrel 52 mg / 1 vložek - plastični maternični vložki z dodatkom progestogenov

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bayer d.o.o. - levonorgestrel - intrauterini dostavni sistem - levonorgestrel 19,5 mg / 1 sistem - plastični maternični vložki z dodatkom progestogenov

Európai Unió - szlovén - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamid - prostatične neoplazme - endokrini terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

oktreotid - prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje - oktreotid 10 mg / 1 viala - oktreotid

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

oktreotid - prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje - oktreotid 20 mg / 1 viala - oktreotid

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

oktreotid - prašek in vehikel za suspenzijo s podaljšanim sproščanjem za injiciranje - oktreotid 30 mg / 1 viala - oktreotid

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

novo nordisk a/s - estradiol; noretisteronacetat - filmsko obložena tableta - estradiol 2 mg / 1 tableta  noretisteronacetat1 mg / 1 tableta; noretisteronacetat 1 mg / 1 tableta - noretisteron in estrogen

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

novo nordisk a/s - estradiol - filmsko obložena tableta - estradiol 1 mg / 1 tableta - noretisteron in estrogen

Európai Unió - szlovén - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degareliks - prostatične neoplazme - endokrini terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Szlovénia - szlovén - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

fulvestrant - raztopina za injiciranje v napolnjeni injekcijski brizgi - fulvestrant 250 mg / 1 brizga - fulvestrant